title: Regulatory concerns at various phases of drug development.
authors.affiliation: Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, USA.
authors.forename: S
authors.initials: S
authors.lastname: Aurecchia
authors.forename: D
authors.initials: D
authors.lastname: Orloff
authors.forename: S
authors.initials: S
authors.lastname: Sobel
mesh_terms: D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000592:standards*; D015195:Drug Design; D004341:Drug Evaluation / Q000592:standards*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007880:Legislation, Drug / Q000592:standards*; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000960:Hypolipidemic Agents